Oncology nurse practitioners discuss CD38-based frontline therapy for newly diagnosed multiple myeloma, including Dara-VRd efficacy, AE management, and subcutaneous administration strategies.
Multiple Myeloma: Administration Insights
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Belzutifan/Pembrolizumab for Adjuvant Renal Cell Carcinoma
2
How Nurses Can Save Lives Beyond the Bedside
3
GLP-1s and Breast Cancer: Navigating the Link Between Weight and Risk
4
Addressing Patients’ Sexual Health and Body Image in Oncology Nursing
5